Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/25 09:30 | 12/15/25 | RLMD | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | 2 | P.d | 713 | 2.38 | 0 | 300 | 30 | 1,300 | D | ||||||||||||||
12/16/25 09:30 | 12/15/25 | RLMD | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | FL | O | CFO | 2 | P.d | 1,148 | 2.24 | 0 | 512 | 177 | 800 | D | ||||||||||||||
11/6/25 07:30 | 11/5/25 | RLMD | Health | Drug | Pharmaceutical Preparations | Ence Chuck | FL | O | CAO,COO | 1 | P | 299 | 2.20 | 0 | 136 | 51 | 404 | D | ||||||||||||||
11/6/25 07:30 | 11/5/25 | RLMD | Health | Drug | Pharmaceutical Preparations | Kelly Paul Edward | FL | DO | COO | 1 | P | 198 | 2.20 | 0 | 90 | 22 | 502 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |